Cannabis and psychosis: what do we know and what should we do?
The British Journal of Psychiatry April 1, 2018 DOI: 10.1192/bjp.2018.1 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Commentary Peer reviewed |
|---|---|
| Topics | Cannabis |
| Key points | Argues that heavy cannabis use increases psychosis risk in a dose-dependent manner, with high-potency preparations and synthetic cannabinoids posing the greatest risk, and advises waiting for evidence from North American legalization models before adopting similar policies. |
Abstract
Summary: It is now incontrovertible that heavy use of cannabis increases the risk of psychosis. There is a dose–response relationship and high potency preparations and synthetic cannabinoids carry the greatest risk. It would be wise to await the outcome of the different models of legalisation that are being introduced in North America, before deciding whether or not to follow suit. Declaration of interest: None.
Citations in the library
Cited by 14
- Cannabis and Psychosis: Are We any Closer to Understanding the Relationship? Current Psychiatry Reports June 4, 2019
- Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition Frontiers in Psychology May 14, 2020
- Cognitive mechanisms in cannabis-related paranoia; Initial testing and model proposal Psychosis May 13, 2020
- The Construct of Medical and Non-Medical Marijuana—Critical Review International Journal of Environmental Research and Public Health February 27, 2022
- Cannabis Use and Psychosis – Modern Views on the Problem. Narrative Synthesis Medicina 2021
and 9 more in the library